Pain Therapeutics Cash Flow - Annual (NASDAQ:PTIE)

Add to My Stocks
$0.96 $0.01 (1.05%) PTIE stock closing price Sep 18, 2018 (Closing)

The Pain Therapeutics cash flow statement helps investors understand how well the company is managing its cash flows. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Pain Therapeutics profits and Pain Therapeutics debt. Pain Therapeutics had cash and cash equivalents of $16.61M at beginning of the year and $10.47M at year end for 2017. Pain Therapeutics cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. Pain Therapeutics had an outflow of $-8.23M from operating activities, $- spend due to financing activities, and $2.1M inflow due to investing activities for 2017.

View details of Pain Therapeutics cash flows for latest & last 10 financial years
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow----------
Net Increase (Decrease) in Assets Liabilities--1.76M1.59M-0.93M-0.02M-0.1M6.17M1.05M-18.35M-16.18M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net2.97M4.32M3.45M3.75M-38.46M-3.74M-3.98M10.59M6.87M11.54M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment--0.07M-0.19M-0.08M------
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments2.1M-2.09M-1.25M5.65M17.62M59.9M52.46M-103.22M80.23M
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares------0.3M9.04M2.08M--25.1M
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities--0.28M-0.04M---33.93M-0.33M-85.4M-0.01M-
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year16.61M31.29M40.59M48.58M49.35M73.14M4.79M35.79M153.15M86.56M
Cash & Equivalents at Year End10.47M16.61M31.29M40.59M48.58M49.35M73.14M4.79M35.79M153.15M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Click here to view our Durect financial analysis

Pain Therapeutics stock price history provides insight into historical stock price fluctuations, and Pain Therapeutics stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Pain Therapeutics has cash of $10.47M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Pain Therapeutics stock price.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Pain Therapeutics lost $-8.23M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $2.1M for PTIE in last 2017 report.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $- for Pain Therapeutics.

Key Financial Ratios For Pain Therapeutics Cash Flow

FCF margin

Annual Cash Flow Statements For Pain Therapeutics, Inc. Peers

Durect cash flow, Egalet cash flow, KemPharma cash flow, Tonix Pharma cash flow